Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) shot up 10.5% during mid-day trading on Friday . The stock traded as high as C$0.11 and last traded at C$0.11. 572,213 shares were traded during mid-day trading, an increase of 353% from the average session volume of 126,331 shares. The stock had previously closed at C$0.10.
Voyageur Pharmaceuticals Stock Performance
The stock has a market capitalization of C$19.53 million, a price-to-earnings ratio of -14.00 and a beta of 0.32. The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21. The firm has a 50-day moving average of C$0.08 and a 200-day moving average of C$0.06.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
See Also
- Five stocks we like better than Voyageur Pharmaceuticals
- Financial Services Stocks Investing
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- Stock Sentiment Analysis: How it Works
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.